Growth factor regulation and manipulation in wound repair: to scar or not to scar, that is the question

Bibliography

• LEIBOVICH SJ, ROSS R: The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am. J. Pathol.(1975) 78(1):71–100.
   Google Scholar
• ••Seminal publication showing importance ofmacrophages in wound healing.
   Google Scholar
• SINGER AJ, CLARK RA: Cutaneous wound healing. N Engl. J. Med.(1999) 341(10):738–746.
   PubMed Web of Science ®Google Scholar
• •Review of process of cutaneous wound healing.
   Google Scholar
• CHAN ED, AUGUSTIN A, LAPADAT R, RICHES DWH: Inflammation in the pathogenesis of interstitial lung disease. In: Interstitial Lung Disease.Schwarz MI (Ed.), Mosby, St. Louis, MO, USA (1998).
   Google Scholar
• •Review of inflammatory mediators and growth factors in pulmonary disease.
   Google Scholar
• HELDIN CH, WESTERMARK B: Mechanism of action and in vivo role of platelet-derived growth factor. Physic] Rev(1999) 79(4):1283–1316.
   PubMed Web of Science ®Google Scholar
• ROSENKRANZ S, KAZLAUSKAS A: Evidence for distinct signaling properties and biological responses induced by the PDGF receptor a and 13 subtypes. Growth Factors(1999) 16(3):201–2016.
   PubMed Web of Science ®Google Scholar
• LASKY JA, BRODY AR: Interstitial fibrosis and growth factors. Environ. Health Perspect.(2000) 108\(Suppl. 4):751–762.
   Google Scholar
• •Recent review of growth factors in pulmonary fibrosis.
   Google Scholar
• COOPER DM, YU EZ, HENNESSEY P, KO F, ROBSON MC: Determination of endogenous cytokines in chronic wounds. Ann. Sorg.(1994) 219(6):688–691.
   PubMed Web of Science ®Google Scholar
• KALLIANINEN LK, HIRSHBERG J, MARCHANT B, REES RS: Role of platelet-derived growth factor as an adjunct to surgery in the management of pressure ulcers. Plast. Recoristr. Sorg.(2000) 106(6):1243–1248.
   Google Scholar
• EMING SA, MEDALIE DA, TOMPKINS RG, YARMUSH ML MORGAN JR: Genetically modified human keratinocytes overexpressing PDGF-A enhance the performance of a composite skin graft. Hum. Gene Ther.(1998) 9(4):529–539.
   Google Scholar
• EMING SA, WHITSITT JS, HE L et al:Particle-mediated gene transfer of PDGF isoforms promotes wound repair. J. Invest. Dermatol(1999) 112(3):297–302.
   PubMed Web of Science ®Google Scholar
• WIEMAN TJ: Clinical efficacy of becaplermin (rhPDGF-BB) gel. Becaplermin Gel Studies Group. Am. J. Sorg.(1998) 176(Suppl. 2A):745–795.
   Google Scholar
• ROBSON MC, MUSTOE TA HUNT TK: The future of recombinant growth factors in wound healing. Am J Sorg.(1998) 176(Suppl. 2A):805–825.
   Google Scholar
• LETTERIO JJ, ROBERTS AB: Regulation of immune responses by TGF-I3. Anna Rev Immuriol(1998) 16:137–161.
   PubMed Web of Science ®Google Scholar
• PIEK E, HELDIN CH, TEN DUKE P: Specificity, diversity, and regulation in TGF-13 superfamily signaling. FASEB J.(1999) 13(15):2105–2124.
   PubMed Web of Science ®Google Scholar
• CROWE MJ, DOETSCHMAN T GREENHALGH DG: Delayed wound healing in immunodeficient TGF-I3 1 knockout mice. J. Invest. Dermatol(2000) 115(1):3–11.
   PubMed Web of Science ®Google Scholar
• •Knockout evidence for role of TGF-P in wound healing.
   Google Scholar
• OKUDA K, MURATA M, SUGIMOTO M et al.:TGF-I31 influences early gingival wound healing in rats: an immunohistochemical evaluation of stromal remodelling by extracellular matrix molecules and PCNA. J. Oral. Pathol Med.(1998) 27(10):463–469.
   PubMed Web of Science ®Google Scholar
• TYRONE JW, MARCUS JR, BONOMO SR et al.:Transforming growth factor 133 promotes fascial wound healing in a new animal model. Arch. Sorg.(2000) 135(10):1154–1159.
   Google Scholar
• SCHMID P, ITIN P, CHERRY G, BI C, COX DA: Enhanced expression of transforming growth factor-I3 type I and type II receptors in wound granulation tissue and hypertrophic scar. Am. J. Pathol(1998) 152(2):485–493.
   Google Scholar
• BRAHMATEWARI J, SERAFINI A, SERRALTA V, MERTZ P, M EAGLSTEIN WH: The effects of topical transforming growth factor-I32 and anti- transforming growth factor-I32,3 on scarring in pigs. J. Cutari. Med. Surg.(2000) 4(3):126–131.
   Google Scholar
• TRED GET EE, SHANKOWSKY HA, PANNU R et al:Transforming growth factor-I3 in thermally injured patients with hypertrophic scars: effects of interferon a-213. Plast. Reconstr. Surg.(1998) 102(5):1317–1328; Discussion 1329–1330.
   Google Scholar
• MASSAGUE J: TGF-I3 signal transduction.Ann. Rev Biochem.(1998) 67:753–791.
   Google Scholar
• MASSAGUE J, WOTTON D: Transcriptional control by the TGF-I3/Smad signaling system. Embo J.(2000) 19(8):1745–1754.
   PubMed Web of Science ®Google Scholar
• KLINT P, CLAESSON-WELSH L: Signal transduction by fibroblast growth factor receptors. Front. Biosci.(1999) 4:D165–177.
   PubMedGoogle Scholar
• ORNITZ DM: FGFs, heparan sulfate and FGFRs: complex interactions essential for development. Bioessays(2000) 22 (2): 108–112.
   PubMed Web of Science ®Google Scholar
• POWERS CJ, MCLESKEY SW, WELLSTEIN A: Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer(2000) 7(3):165–197.
   PubMed Web of Science ®Google Scholar
• WANG DI, GOTLIEB AT: Fibroblast growth factor 2 enhances early stages of in vitro endothelial repair by microfilament bundle reorganization and cell elongation. Exp. Mol. Pathol.(1999) 66(3):179–190.
   PubMed Web of Science ®Google Scholar
• FU X, SHEN Z, CHEN Y et al.:Randomised placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns. Lancet (1998)352(9141):1661–1664.
   Google Scholar
• ORTEGA S, ITTMANN M, TSANG SH, EHRLICH M, BASILICO C: Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc. Natl. Acad. Sci. USA(1998) 95(10):5672–5677.
   PubMed Web of Science ®Google Scholar
• ZHOU M, SUTLIFF RL, PAUL RJ et al.:Fibroblast growth factor 2 control of vascular tone. Nat. Med.(1998) 4(2):201–207.
   PubMed Web of Science ®Google Scholar
• XIA Y, ZHAO Y, MARCUS J etal.:Effects of keratinocyte growth factor-2 (KGF-2) on wound healing ma n ischaemia-impared rabbit ear model and on scar formation. Pathol.(1999) 188:431–438.
   Google Scholar
• NUGENT MA, IOZZO RV: Fibroblast growth factor-2. Int. j Biochem. Cell. Biol.(2000) 32(2):115–120.
   PubMed Web of Science ®Google Scholar
• SMITH PD, KUHN MA, FRANZ MG et al.:Initiating the inflammatory phase of incisional healing prior to tissue injury. Surg. Res.(2000) 92(1):11–17.
   Google Scholar
• KRALL G, BROUG J, VAN IWAARDEN, PERSOONS J, THEPEN T: The role of alveolar macrophages in pulmonary immune function. In: Lung Macrophagesand Dendritic Cells in Health and Disease. Lipscomb SRIVI (Ed.) Marcel Dekker, Inc., New York, NY, USA (1995).
   Google Scholar
• THEPEN T, KRAAL G, HOLT PG: The role of alveolar macrophages in regulation of lung inflammation. Ann. NY Acad. Sri.(1994) 725:200–206.
   PubMed Web of Science ®Google Scholar
• MIYAZAKI Y, ARAKI K, VESIN C et al.:Expression of a tumor necrosis factor-a transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. j Chia. Invest.(1995) 96(1):250–259.
   PubMed Web of Science ®Google Scholar
• •Transgenic evidencethatinflammationisdirectly related to pulmonary fibrosis.
   Google Scholar
• RAGHU G, CHEN YY, RUSCH V RABINOVITCH PS: Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs. Am. Rev Respir: Dis.(1988) 138(3):703–708.
   Google Scholar
• KHALIL N, BEREZNAY 0, SPORN M, GREENBERG AH: Macrophage production of transforming growth factor P and fibroblast collagen synthesis in chronic pulmonary inflammation. I Exp. Med.(1989) 170(3):727–737.
   PubMed Web of Science ®Google Scholar
• PHAN SH, KUNKEL SL: Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp. Lung Res.(1992) 18 (1):29–43.
   PubMed Web of Science ®Google Scholar
• SHAH M, FOREMAN DM, FERGUSON MW: Neutralisation of TGF-I3 1 and TGF-13 2 or exogenous addition of TGF-I3 3 to cutaneous rat wounds reduces scarring. Cell Sci(1995) 108\(Part 3):985–1002.
   Google Scholar
• •Controversial report suggesting TGF-P3 canreduceTGF-P1 and132andscarformation.
   Google Scholar
• FAD OK VA, BRATTON DL, KONOWAL A et al.:Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-I3, PGE2, and PAR j Chi]. Invest.(1998) 101(4):890–898.
   Google Scholar
• ••Seminal publicationshowingtheimportanceofTGF-P in resolutionof inflammation.
   Google Scholar
• LASKY JA, ORTIZ LA, TONTHAT B et al.:Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. Am. J Physiol.(1998) 275(2, Part 1):L365–371.
   Google Scholar
• YANG DH, KIM HS, WILSON EM, ROSENFELD RG, OH, Y: Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGEBP-rP2 expression by TGF-I3 in Hs578T human breast cancer cells. J. Clin. Endocrinol. Metab.(1998) 83(7):2593–2596.
   Google Scholar
• ALLEN JT, KNIGHT RA, BLOOR CA, SPITERI MA: Enhanced insulin-like growth factor binding protein-related protein 2 (Connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am. j Respir Cell. Ma. Biol.(1999) 21(6):693–700.
   PubMed Web of Science ®Google Scholar
• DAMMEIER J, BEER HD, BRAUCHLE M WERNER S: Dexamethasone is a novel potent inducer of connective tissue growth factor expression. Implications for glucocorticoid therapy. _J. Biol. Chem.(1998) 273(29):18185–18190.
   Google Scholar
• MARTINET Y, ROM WN, GROTENDORST GR, MARTIN GR, CRYSTAL RG: Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl. Med.(1987) 317(4):202–209.
   PubMed Web of Science ®Google Scholar
• NAGAOKA I, TRAPNELL BC, CRYSTAL RG: Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis. I Chi]. Invest.(1990) 85(6):2023–2027.
   PubMed Web of Science ®Google Scholar
• HOYLE GW, LI J, FINKELSTEIN JB et al.:Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. Am. J. Pathol.(1999) 154(6):1763–1775.
   PubMed Web of Science ®Google Scholar
• KALLIO E, KOSKINEN P, BUCHDUNGER E, LEMSTROM K: Inhibition of obliterative bronchiolitis by platelet-derived growth factor receptor protein-tyrosine kinase inhibitor. Transplant Proc.(1999) 31(1-2):187.
   Google Scholar
• RICE AB, MOOMAW CR, MORGAN DL, BONNER JC: Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. Am. Pathol(1999) 155(1):213–221.
   Google Scholar
• MADTES DK, RUBENFELD G, KLIMA LD et al:Elevated transforming growth factor-a levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Am. j Respir Grit. Care Med.(1998) 158(2):424–430.
   PubMed Web of Science ®Google Scholar
• RAPPOLEE DA, MARK D, BANDA MJ, WERB Z: Wound macrophages express TGF-a and other growth factors in vivo:analysis by mRNA phenotyping. Science(1988) 241(4866):708–712.
   PubMed Web of Science ®Google Scholar
• LIU JY, MORRIS GF, LEI WH, CORTI M, BRODY AR: Up-regulated expression of transforming growth factor-a in the bronchiolar-alveolar duct regions of asbestos-exposed rats. Am. I Pathol(1996) 149(1):205–217.
   Google Scholar
• MADTES DK, BUSBY HK, STRANDJORD TP, CLARK JG: Expression of transforming growth factor-a and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats. Am. I Respir: Cell. Mol. Biol.(1994) 11(5):540–551.
   Google Scholar
• KORFHAGEN TR, SWANTZ RJ, WERT SE et al.:Respiratory epithelial cell expression of human transforming growth factor-a induces lung fibrosis in transgenic mice. j Clin. Invest.(1994) 93(4):1691–1699.
   Google Scholar
• WERNER S, PETERS KG, LONGAKER MT et al:Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc. Nat] Acad. Li. USA(1992) 89(15):6896–6900.
   Google Scholar
• WERNER S, SMOLA H, LIAO X etal.:The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science(1994) 266(5186):819–822.
   Google Scholar
• HENKE C, MARINEILI W, JESSURUN J et al.:Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury. Am. I Pathol(1993) 143(4):1189–1199.
   PubMed Web of Science ®Google Scholar
• INOUE Y, KING TE, JR., TINKLE SS, DOCKSTADER K NEWMAN LS: Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders. Am. Pathol(1996) 149(6):2037–2054.
   Google Scholar
• ASTON C, JAGIRDAR J, LEE TC et al.:Enhanced insulin-like growth factor molecules in idiopathic pulmonary fibrosis. Am. J Respir: Crit. Care Med. (1995)151(5):1597–1603.
   Google Scholar
• UH ST, INOUE Y, KING TE, JR et al:Morphometric analysis of insulin-like growth factor-I localization in lung tissues of patients with idiopathic pulmonary fibrosis. Am. j Respir. Grit. Care Med.(1998) 158(5 Part 1):1626–1635.
   Google Scholar
• KREIN PM, SABATINI PJB, TINMOUTH W, GREEN FHY, WINSTON BW.: Localization of insulin-like growth factor-I in lung tissues of patients with acute respiratory distress syndrome: Am. I Respir: Crit. Care Med.(2001). Submitted.
   Google Scholar
• NOBLE PW, HENSON PM RICHES DW: Insulin-like growth factor-1 (IGF-1) mRNA expression in bone marrow derived macrophages is stimulated by chrysotile asbestos and bleomycin. A potential marker for a reparative macrophage phenotype. Chest(1991) 99\(Suppl. 3):795–805.
   Google Scholar
• MAEDA A, HIYAMA K, YAMAKIDO H, ISHIOKA S YAMAKIDO M: Increased expression of platelet-derived growth factor A and insulin-like growth factor-I in BAL cells during the development of bleomycin-induced pulmonary fibrosis in mice. Chest(1996) 109(3):780–786.
   Google Scholar
• OLBRUCK H, SEEMAYER NH, VOSS B WILHELM M: Supernatants from quartz dust treated human macrophages stimulate cell proliferation of different human lung cells as well as collagen- synthesis of human diploid lung fibroblasts in vitro. Toxicol Lett.(1998) 96–97:85–95.
   Google Scholar
• HARRISON NK, CAMBREY AD, MYERS AR etal.:Insulin-like growth factor-I is partially responsible for fibroblast proliferation induced by bronchoalveolar lavage fluid from patients with systemic sclerosis. Clin. Sci. (Colch)(1994) 86(2):141–148.
   Google Scholar
• ALLEN JT, BLOOR CA, KNIGHT RA SPITERI MA: Expression of insulin-like growth factor binding proteins in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. Am. I Respir: Cell. Mol Biol.(1998) 19(2):250–258.
   Google Scholar
• GOLDSTEIN RH, POLIKS CF, PILCH PF, SMITH BD, FINE A: Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts. Endocrinology(1989) 124:964–970.
   PubMed Web of Science ®Google Scholar
• GILLERY P, LEPERRE A, MAQUART FX, BOREL JP: Insulin-like growth factor-I (IGF-I) stimulates protein synthesis and collagen gene expression in monolayer and lattice cultures of fibroblasts. I Cell. Physiol(1992) 152(2):389–396.
   PubMed Web of Science ®Google Scholar
• SELMAN M, RUIZ V, CABRERA S et al:TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?. Am. I Physiol Lung Cell Mol Physiol(2000) 279(3)1562–574.
   Google Scholar
• SHAPIRO SD: The macrophage in chronic obstructive pulmonary disease. Am. Respir: Crit. Care Med.(1999) 160(5 Part 2):S29–32.
   Google Scholar
• ADZICK NS LORENZ HP: Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair. Ann. Surg.(1994) 220(1):10–18.
   Google Scholar
• ••Propose theory of immunologic poisoningwhich causes scar formation.
   Google Scholar
• STELNICKI EJ, CHIN GS, GITTES GK, LONGAKE MT: Fetal wound repair: where do we go from here? &min. Pediam Surg.(1999) 8(3):124–130.
   Google Scholar
• •Review of foetal wound healing and perspectives for future work.
   Google Scholar
• FRANTZ FW, BETTINGER DA, HAYNES JH et al.:Biology of fetal repair: the presence of bacteria in fetal wounds induces an adult-like healing response. Pediatr. Surg.(1993) 28(3):428–433.
   Google Scholar
• LIECHTY KW, ADZICK NS, CROMBLEHOLME TM: Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair. Cytokine(2000) 12(6):671–676.
   PubMed Web of Science ®Google Scholar
• LIECHTY KW, CROMBLEHOLME TM, CASS DL, MARTIN B, ADZICK NS: Diminished interleukin-8 (IL-8) production in the fetal wound healing response. I Surg. Res.(1998) 77(1):80–84.
   Google Scholar
• LIECHTY KW, KIM HB, ADZICK NS, CROMBLEHOLME TM: Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair. Pediam Surg.(2000) 35(6):866–872.
   PubMed Web of Science ®Google Scholar
• •Evidence that an active anti-inflammatory state exists in foetal healing.
   Google Scholar
• OLUTOYE 00, YAGER DR, COHEN IK, DIEGELMANN RF: Lower cytokine release by fetal porcine platelets: a possible explanation for reduced inflammation after fetal wounding. I PedMm Surg.(1996) 31(1):91–95.
   Google Scholar
• OLUTOYE 00, BARONE EJ, YAGER DR et al.:Hyaluronic acid inhibits fetal platelet function: implications in scarless healing. j Pediatr. Surg.(1997) 32(7):1037–1040.
   Google Scholar
• JENNINGS RW, ADZICK NS, LONGAKER MT et al.:Ontogeny of fetal sheep polymorphonuclear leukocyte phagocytosis. I Pediati: Surg.(1991) 26(7):853–855.
   Google Scholar
• SULLIVAN KM, LORENZ HP, MEULI M, LIN RY ADZICK NS: A model of scarless human fetal wound repair is deficient in transforming growth factor 11 Pediati: Surg.(1995) 30(2):198–202.
   Google Scholar
• WHITBY DJ, FERGUSON MW: Immunohistochemical localization of growth factors in fetal wound healing. Dev. Biol.(1991) 147(1):207–215.
   PubMed Web of Science ®Google Scholar
• ADZICK NS, HARRISON MR, GLICK PL et al:Comparison of fetal, newborn, and adult wound healing by histologic, enzyme-histochemical, and hydroxyproline determinations. j Pediatr. Surg.(1985) 20(4):315–319.
   Google Scholar
• HOPKINSON-WOOLLEY J, HUGHES D, GORDON S, MARTIN P: Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J. Cell Sci.(1994) 107\(Part 5):1159–1167.
   Google Scholar
• LANNING DA, NWOMEH BC, MONTANTE SJ et al.:TGF-I31 alters the healing of cutaneous fetal excisional wounds. J. Pediati: Surg.(1999) 34(5):695–700.
   Google Scholar
• KRUMMEL TM, MICHNA BA, THOMAS BL et al:Transforming growth factor 13 (TGF-13) induces fibrosis in a fetal wound model. j. Pediatr. Surg.(1988) 23(7):647–652.
   PubMed Web of Science ®Google Scholar
• SOO C, HU FY, ZHANG X et al.:Differential expression of fibromodulin, a transforming growth factor- 13 modulator, in fetal skin development and scarless repair. Am. J Patna.(2000) 157(2):423–433.
   Google Scholar
• SHAH M, FOREMAN DM, FERGUSON MW: Control of scarring in adult wounds by neutralising antibody to transforming growth factor 11 Lancet(1992) 339(8787):213–214.
   Google Scholar
• HAYNES JH, JOHNSON DE, MAST BA etal.:Platelet-derived growth factor induces fetal wound fibrosis. j Pediatr. Surg.(1994) 29(11):1405–1408.
   Google Scholar
• DURHAM L A, KRUMMEL TM, CAWTHORN JW, THOMAS BL, DIEGELMANN RF: Analysis of transforming growth factor 13 receptor binding in embryonic, fetal, and adult rabbit fibroblasts. j Pediatr. Surg.(1989) 24 (8) :784–788.
   Google Scholar
• BROKER BJ, CHAKRABARTI R, BLYNMAN T et al.:Comparison of growth factor expression in fetal and adult fibroblasts: a preliminary report. Arch. Otolaryngol. Head Neck Surg.(1999) 125(6):676–680.
   Google Scholar
• EMOTO H, TAGASHIRA S, MATTEI MG et al.:Structure and expression of human fibroblast growth factor 10.1 BM Chem.(1994) 272:23191-23194. Patents
   Google Scholar